Chinese (Simplified)EnglishFrenchGermanItalianJapanesePortugueseRussianSpanish
No Result
View All Result
FuturoProssimo
Sunday, April 18, 2021
  • Tech
  • Medicine
  • Society
  • Ambience
  • Spazio
  • Transportation
  • concepts
  • H+
Contact
FuturoProssimo
No Result
View All Result

Read in:
Chinese (Simplified)EnglishFrenchGermanItalianJapanesePortugueseRussianSpanish

November 22, 2020

Vaccine against melanoma: it is now twice as powerful

Gianluca Ricciodi Gianluca Riccio
in Medicine
Send to FacebookPin on PinterestSend on TwitterSend on Whatsappon Linkedin
Vaccine against melanoma: it is now twice as powerful

By adding two ingredients to the melanoma vaccine, a team from Mount Sinai doubles its potency - it could now stop relapses.

Adding two new elements to the melanoma vaccine could help prevent relapses.

Remember when I spoke to you development of a melanoma vaccine in December 2019? No, right? It seems like a century has passed.

Maybe you are also interested

Glioblastoma, breakthrough in the treatment of this dangerous brain cancer

First human tests of the brain cancer vaccine completed

Regenerating therapy, we are now one step away: there are just 5 years left.

OncoHost, artificial intelligence that can “design” oncological therapies

Yet its development continues, with ever better news.

Skin cancer is the most common type of cancer - luckily, it's also one of the least dangerous, unless it's a melanoma. Although less common, this type of cancer is more aggressive.

It grows and spreads faster and is responsible for the vast majority of skin cancer deaths. If caught and treated early, melanoma is highly treatable, with a 5-year survival rate of 92%, but there is always a risk of it coming back.

Now, a team of researchers has found a way to potentially reduce that risk by doubling the effect of the new melanoma vaccine.

Improving a Melanoma Vaccine

The melanoma vaccine, CDX-1401, was developed by the American biotechnology company Celldex Therapeutics.

It is designed to prevent skin cancer from coming back by targeting immune cells (called dendritic cells) to activate antibodies and T cells, which can then fight the melanoma if it returns.

In a new clinical study, reported in Nature Cancer, the team from Mount Sinai in New Jersey enrolled 60 patients who had stage 2 or 3 melanoma removed by surgery.

Half of the participants received four doses of the melanoma vaccine over four months.

The other half received the vaccine, plus two ingredients: a molecule called Flt3L and an immunostimulant.

Vaccine melanoma relapses
Vaccine against melanoma: the new, more powerful formulation could prevent recurrence

The results

The researchers' hypothesis was correct: the extra ingredients boosted the immune response, essentially doubling the effect of the vaccine.

After administering all doses of the melanoma vaccine, the researchers analyzed their levels of T cells and antibodies. They found that the extra ingredients greatly increased the immune response.

The molecule (Flt3L) increased the number of dendritic cells, while the immunostimulant improved the ability of the cells to trigger the production of antibodies and T cells.

"These positive results are significant not only for improving cancer vaccines, but also potentially for application to other vaccine platforms," ​​said the researcher. Steven Fling in a press release .

Preventing relapses of melanoma

While this news is promising, the vaccine has yet to prove itself in larger Phase 3 trials and gain FDA approval before doctors can administer it outside of a clinical trial.

The stronger immune response could translate into fewer skin cancers, so the researchers will follow study participants to see how many in each group will have melanoma relapses in the years to come. 

Only in this way will it be possible to understand the ability of the melanoma vaccine to prevent relapse.

tags: cancerMelanomavaccine
Previous post

Agriculture and photovoltaics? Agrivoltaico: you don't know what awaits you

Next article

How the construction site of the future changes: the advent of robot construction

Collaborate!

We are open to visions about the future. Submit an article, disclose the results of a search or scientific discoveries, shows points of view on a theme, tells about a change.

Contact us

Most read of the week

  • US intelligence analyzes the future, and it doesn't look good at all

    US intelligence analyzes the future, and it doesn't look good at all

    109 shares
    Share 43 Tweet 27
  • Plants that “exude” metal: can agromining replace mines?

    68 shares
    Share 27 Tweet 17
  • Physicists at Microsoft think the universe is a self-taught computer

    75 shares
    Share 30 Tweet 19
  • The rising of the sea is unstoppable. You need to think big

    50 shares
    Share 20 Tweet 12
The last
Ambience

Because algae can save the environment

Medicine

Sleep Alarm: Does Technology Really Destroy Our Circadian Rhythm?

Medicine

Covid, a team identifies genes that can fight infection

concepts

The underwater rescue drone goes where no man can

archive

Next article
How the construction site of the future changes: the advent of robot construction

How the construction site of the future changes: the advent of robot construction

Facebook

Instagram

Telegram

Twitter

Clubhouse

Near future

Futuroprossimo.it is an Italian futurology resource open since 2006: every day news about the near future. Scientific discoveries, medical research, prototypes, concepts and predictions about the future for free.

Tag

Ambience Architecture Club Communication concepts Advice Economy Energy Events Gadgets The future of yesterday The newspaper of tomorrow Italy Next Medicine Military Weather Robotica Society Spazio Technology transhumanism Transportation Video

The author

Gianluca Riccio, copywriter and journalist - Born in 1975, he is the creative director of an advertising agency, he is affiliated with the Italian Institute for the Future, World Future Society and H +, Network of Italian Transhumanists.

Home / Author / IDEA / archive / Promo on FP

Collaborate! Are you interested in writing a post on Futuroprossimo? Click here for contacts.

Categories

Creative Commons License
This work is distributed under license Creative Commons Attribution 4.0 International.
© 2021 Futuroprossimo

  • Home
  • Contact
  • archive
  • Technology
  • Medicine
  • Transportation
  • Weather
  • Society
  • Ambience
  • transhumanism

© 2021 Futuroprossimo - Creative Commons License
This work is distributed under license Creative Commons Attribution 4.0 International.

This site uses cookies. By continuing to read it, you consent to their use.